Evidence map›Paper›PMID 41969658›Full record

ArticleFrontiers in cellular and infection microbiology2026

First report on the biological characteristics of carbapenem-resistant

Chunhong Shao, Guangfei Zhou, Lin Li, Yanyan Sang, Xinying Wang, Lingling Wu, Zhijun Zhang

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunhong Shao *Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Provincial Hospital, Jinan, China.
Guangfei Zhou *Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, China.
Lin Li *Pharmacy Intravenous Admixture Services, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, China.
Yanyan SangDepartment of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, China.
Xinying WangDepartment of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, China.
Lingling Wu *Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, China.
Zhijun Zhang *Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the antimicrobial resistance profile and molecular characteristics of the first carbapenem-resistant Methods: A strain of Results: Antimicrobial susceptibility testing revealed that the strain exhibited resistance to penicillins, cephalosporins, quinolones and carbapenem antibiotics. WGS analysis demonstrated that this isolate belonged to ST26 type and carried multiple resistance genes, including Conclusion: The carbapenem resistance mechanism of this

Indexed as

BacteremiaBacterial Outer Membrane Proteinsbeta-LactamasesCarbapenemsPorinsSalmonellaSalmonella InfectionsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsPlasmidsSerotypingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVirulence FactorsWhole Genome SequencingAnti-Bacterial AgentsBacterial Outer Membrane Proteinsbeta-lactamase CMY-2beta-LactamasesCarbapenemsOmpC proteinOmpF proteinPorinsVirulence Factorscarbapenem resistancedrug resistance genesouter membrane proteinSalmonella Thompsonwhole-genome sequencing

Identifiers

PMID41969658
PMCPMC13066298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.